You have 9 free searches left this month | for more free features.

Condition

Retinitis Pigmentosa (2)

Usher Syndrome Type 2 (2)

Deaf Blind (1)

Eye Diseases (1)

Eye Diseases, Hereditary (1)

Eye Disorders Congenital (1)

Retinal Disease (1)

Vision Disorders (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

ProQR Therapeutics (2)

Collaborator

Intervention

rna antisense oligonucleotide for intravitreal injection (1)

sham-procedure (1)

ultevursen (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

ultevursen

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)

Recruiting

Retinitis Pigmentosa
+7 more

Ultevursen
Sham-procedure

San Diego, California
+14 more

Jul 29, 2022

Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for

Terminated

Retinitis Pigmentosa
Usher Syndrome Type 2

RNA antisense oligonucleotide for intravitreal injection

Boston, Massachusetts
+6 more

Dec 12, 2022